Slagle Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $898K | Buy |
4,839
+27
| +0.6% | +$5.01K | 0.36% | 69 |
|
|
2025
Q1 | $1.01M | Sell |
4,812
-276
| -5% | -$57.8K | 0.45% | 59 |
|
|
2024
Q4 | $904K | Sell |
5,088
-316
| -6% | -$56.2K | 0.41% | 61 |
|
|
2024
Q3 | $1.07M | Sell |
5,404
-50
| -0.9% | -$9.87K | 0.47% | 61 |
|
|
2024
Q2 | $936K | Sell |
5,454
-204
| -4% | -$35K | 0.48% | 62 |
|
|
2024
Q1 | $1.03M | Sell |
5,658
-6,890
| -55% | -$1.25M | 0.56% | 63 |
|
|
2023
Q4 | $974K | Buy |
12,548
+5,955
| +90% | +$462K | 0.56% | 59 |
|
|
2023
Q3 | $983K | Sell |
6,593
-233
| -3% | -$34.7K | 0.6% | 59 |
|
|
2023
Q2 | $920K | Buy |
+6,826
| New | +$920K | 0.57% | 60 |
|